‘Skinny’ US FDA User-Fee Reauthorization Would Omit Cosmetics, Supplement Regulation Reforms
Executive Summary
Cosmetics and dietary supplement program reforms may have to wait if Republican Sen. Burr's stripped-down version of US FDA user-fee reauthorization package – which tracks with companion legislation already passed in the House – is the best Congress can do before the August recess.
You may also be interested in...
Cosmetics Industry Still Committed To Reg Modernization, But FDA User-Fee Reauthorization May Not Be Vehicle
A “clean” FDA user-fee reauthorization bill – minus cosmetics modernization provisions – could be the likeliest way forward with user-fee program funding set to elapse at the end of September, a PCPC rep suggested in an email to HBW Insight.
Misbranding Grades Coming For Compliant VMS Labeling If Found Missing From Proposed MPL
Under Senate legislation proposing mandatory listing with FDA for all supplements sold in US, a product labeled in compliance with all other agency regulations would be deemed misbranded if not registered for proposed list.
MDUFA V: US FDA Staff Could See September Lay-Off Notices
The notices normally would go out on 1 August, but unspent user fee funds may be able to sustain work for a few weeks if the program expires.